Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guxian Tablets (骨仙片) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Zhongshan Shaxi Chinese Medicine Factory. It is formulated from a blend of several herbal ingredients, including *Epimedium brevicornu*, *Drynaria fortunei*, *Rehmannia glutinosa*, and *Cuscuta chinensis*. The medication is primarily indicated for the treatment of degenerative bone and joint conditions, such as hyperosteogeny (bone spurs), osteoarthritis, cervical spondylosis, and lumbar muscle strain. In the context of TCM theory, Guxian Tablets function to tonify the kidney, strengthen the skeletal system, and promote blood circulation to alleviate pain and improve mobility. The product is approved for marketing in China and is widely used for age-related or wear-and-tear bone disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guxian tablets.